Sort
17,828 grants matching “crispr”
RP2: Targeting genes and pathways for autophagy-dependent inhibition of bacterial infection
$956,799Ramnik J Xavier · Ut Southwestern Medical Center · U19 · FY2020 · AI
High-Throughput Functional Annotation of Gene Regulatory Elements and Variants Critical to Complex Cellular Phenotypes
$956,415Charles A Gersbach · Duke University · UM1 · FY2021 · HG
Mechanism, Regulation and Application of miRNA pathway in cancer
$956,215Shuo Gu · Division Of Basic Sciences - Nci · ZIA · FY2017 · CA
Single Cell Transciptomics of the Opioid Use Disorder and HIV Syndemic in the Human Brain
$955,944Christine Cheng · University Of California, San Diego · UM1 · FY2022 · DA
Integrative approaches to elucidate p53 transcriptional networks during carcinogenesis
$955,710Laura D Attardi · Stanford University · R35 · FY2022 · CA
Verification of Polymorphisms Impacting Sleep
$953,360Susan Harbison · National Heart, Lung, And Blood Institute · ZIA · FY2025 · HL
Functional and translational studies of RUNX1 and CBFB in hematopoiesis
$953,250Paul Liu · National Human Genome Research Institute · ZIA · FY2018 · HG
New Paradigms for Targeting Truncal Driver Mutations
$953,025William G Kaelin · Dana-Farber Cancer Inst · R35 · FY2019 · CA
Mechanisms and Vulnerabilities of SWI/SNF chromatin remodeling complex mutant lung cancer
$952,822Yonathan Lissanu · University Of Tx Md Anderson Can Ctr · R37 · FY2025 · CA
Exploring DNA damage response pathways as targets for cancer therapy
$952,560Junjie Chen · University Of Tx Md Anderson Can Ctr · R35 · FY2023 · CA
Studying factors controlling cancer progression and immune recognition in mouse models
$951,640Tyler E Jacks · Massachusetts Institute Of Technology · R35 · FY2025 · CA
A nonhuman primate model of stem cell transplantation to understand determinants of post-transplant SIV clearance
$950,729Jonah B. Sacha · Oregon Health & Science University · R01 · FY2021 · AI
Identifying Metabolic Dependencies of Pancreatic Cancers
$950,516Alec Kimmelman · New York University School Of Medicine · R35 · FY2020 · CA
Integrative approaches to elucidate p53 transcriptional networks during carcinogenesis
$949,950Laura D Attardi · Stanford University · R35 · FY2019 · CA
Airway epithelial cell gene regulation: new mechanisms and therapeutic strategies
$949,619David J Erle · University Of California, San Francisco · R35 · FY2024 · HL
Synthetic organogenesis: new paradigms in reconstituting human organ development in vitro
$948,236Mijo Simunovic · Columbia Univ New York Morningside · DP2 · FY2024 · HD
The von Hippel-Lindau Tumor Suppressor Gene and Kidney Cancer: Insights into Oxygen Sensing and Treating Cancers Caused by Undruggable Mutations
$947,910William G Kaelin · Dana-Farber Cancer Inst · R35 · FY2024 · CA
NHGRI/DIR Genomics Core
$947,326Settara Chandrasekharappa · National Human Genome Research Institute · ZIC · FY2022 · HG
Organoid-based Discovery of Oncogenic Drivers and Treatment Resistance Mechanisms
$946,646Calvin J Kuo · Stanford University · U01 · FY2021 · CA
A nonhuman primate model of stem cell transplantation to understand determinants of post-transplant SIV clearance
$946,593Jonah B. Sacha · Oregon Health & Science University · R01 · FY2020 · AI
Organoid-based Discovery of Oncogenic Drivers and Treatment Resistance Mechanisms
$946,509Calvin J Kuo · Stanford University · U01 · FY2020 · CA
Organoid-based Discovery of Oncogenic Drivers and Treatment Resistance Mechanisms
$946,251Calvin J Kuo · Stanford University · U01 · FY2018 · CA
Organoid-based Discovery of Oncogenic Drivers and Treatment Resistance Mechanisms
$946,126Calvin J Kuo · Stanford University · U01 · FY2017 · CA
Mobile Group II Introns and Their Reverse Transcriptases
$945,743Alan M. Lambowitz · University Of Texas At Austin · R01 · FY2019 · GM
Mobile Group II Introns and Their Reverse Transcriptases
$945,743Alan M. Lambowitz · University Of Texas At Austin · R01 · FY2017 · GM